Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 178

1.

Clinical Variants of New Delhi Metallo-β-Lactamase Are Evolving To Overcome Zinc Scarcity.

Stewart AC, Bethel CR, VanPelt J, Bergstrom A, Cheng Z, Miller CG, Williams C, Poth R, Morris M, Lahey O, Nix JC, Tierney DL, Page RC, Crowder MW, Bonomo RA, Fast W.

ACS Infect Dis. 2017 Dec 8;3(12):927-940. doi: 10.1021/acsinfecdis.7b00128. Epub 2017 Oct 11.

PMID:
28965402
2.

Hepatocyte Hyperproliferation upon Liver-Specific Co-disruption of Thioredoxin-1, Thioredoxin Reductase-1, and Glutathione Reductase.

Prigge JR, Coppo L, Martin SS, Ogata F, Miller CG, Bruschwein MD, Orlicky DJ, Shearn CT, Kundert JA, Lytchier J, Herr AE, Mattsson Å, Taylor MP, Gustafsson TN, Arnér ESJ, Holmgren A, Schmidt EE.

Cell Rep. 2017 Jun 27;19(13):2771-2781. doi: 10.1016/j.celrep.2017.06.019.

3.

Development of an imaging mitigation strategy for patient enrolment in the tanezumab nerve growth factor inhibitor (NGF-ab) program with a focus on eligibility assessment.

Roemer FW, Miller CG, West CR, Brown MT, Sherlock SP, Kompel AJ, Diaz L, Galante N, Crema MD, Guermazi A.

Semin Arthritis Rheum. 2017 Dec;47(3):323-330. doi: 10.1016/j.semarthrit.2017.05.008. Epub 2017 May 20.

PMID:
28624172
4.

Evaluation of Quantitative Computed Tomography Cortical Hip Quadrant in a Clinical Trial With Rosiglitazone: A Potential New Study Endpoint.

Miller CG, Bogado CC, Nino AJ, Northcutt AR, Yu HJ, Lewiecki EM, Paul G, Cobitz AR, Wooddell MJ, Bilezikian JP, Fitzpatrick LA.

J Clin Densitom. 2016 Oct;19(4):485-491. doi: 10.1016/j.jocd.2016.02.003. Epub 2016 Mar 24.

PMID:
27052635
5.

Minireview: Fibronectin in retinal disease.

Miller CG, Budoff G, Prenner JL, Schwarzbauer JE.

Exp Biol Med (Maywood). 2017 Jan;242(1):1-7. Epub 2016 Oct 20. Review.

6.

Retina Specialists Treating Diabetic Macular Edema Recommend Different Approaches for Patients Than They Would Choose for Themselves.

Miller CG, Budoff G, Jeng-Miller KW, Fine HF, Roth DB, Prenner JL.

Ophthalmic Surg Lasers Imaging Retina. 2016 Jun 1;47(6):544-54. doi: 10.3928/23258160-20160601-06.

PMID:
27327284
7.

ONE-YEAR OUTCOMES OF A NOVEL TECHNIQUE FOR RESCUING AND SCLERAL FIXATING A POSTERIOR DISLOCATED INTRAOCULAR LENS-BAG COMPLEX WITHOUT CONJUNCTIVAL OPENING (HOFFMAN POCKETS).

Budoff G, Miller CG, Halperin SJ, Jeng-Miller KW, Fine HF, Wheatley HM, Prenner JL.

Retina. 2016 Oct;36(10):1935-40. doi: 10.1097/IAE.0000000000001039.

PMID:
27115994
8.

Sherborn's foraminiferal studies and their influence on the collections at the Natural History Museum, London.

Miller CG.

Zookeys. 2016 Jan 7;(550):71-81. doi: 10.3897/zookeys.550.9863. eCollection 2016.

9.

A DXA Whole Body Composition Cross-Calibration Experience: Evaluation With Humans, Spine, and Whole Body Phantoms.

Krueger D, Libber J, Sanfilippo J, Yu HJ, Horvath B, Miller CG, Binkley N.

J Clin Densitom. 2016 Apr-Jun;19(2):220-5. doi: 10.1016/j.jocd.2015.04.003. Epub 2015 Jun 10.

10.

A double-blind, randomized, Phase III, multicenter study in 358 pediatric subjects receiving isotretinoin therapy demonstrates no effect on pediatric bone mineral density.

Hoover KB, Miller CG, Galante NC, Langman CB.

Osteoporos Int. 2015 Oct;26(10):2441-7. doi: 10.1007/s00198-015-3158-2. Epub 2015 May 9.

PMID:
25956286
11.

OARSI Clinical Trials Recommendations: Hand imaging in clinical trials in osteoarthritis.

Hunter DJ, Arden N, Cicuttini F, Crema MD, Dardzinski B, Duryea J, Guermazi A, Haugen IK, Kloppenburg M, Maheu E, Miller CG, Martel-Pelletier J, Ochoa-Albíztegui RE, Pelletier JP, Peterfy C, Roemer F, Gold GE.

Osteoarthritis Cartilage. 2015 May;23(5):732-46. doi: 10.1016/j.joca.2015.03.003. Review.

12.

OARSI Clinical Trials Recommendations: Hip imaging in clinical trials in osteoarthritis.

Gold GE, Cicuttini F, Crema MD, Eckstein F, Guermazi A, Kijowski R, Link TM, Maheu E, Martel-Pelletier J, Miller CG, Pelletier JP, Peterfy CG, Potter HG, Roemer FW, Hunter DJ.

Osteoarthritis Cartilage. 2015 May;23(5):716-31. doi: 10.1016/j.joca.2015.03.004. Review.

13.

OARSI Clinical Trials Recommendations: Knee imaging in clinical trials in osteoarthritis.

Hunter DJ, Altman RD, Cicuttini F, Crema MD, Duryea J, Eckstein F, Guermazi A, Kijowski R, Link TM, Martel-Pelletier J, Miller CG, Mosher TJ, Ochoa-Albíztegui RE, Pelletier JP, Peterfy C, Raynauld JP, Roemer FW, Totterman SM, Gold GE.

Osteoarthritis Cartilage. 2015 May;23(5):698-715. doi: 10.1016/j.joca.2015.03.012. Review. Erratum in: Osteoarthritis Cartilage. 2015 Aug; 23(8):1434-5.

14.

Imaging atlas for eligibility and on-study safety of potential shoulder adverse events in anti-NGF studies (Part 3).

Roemer FW, Hayes CW, Miller CG, Hoover K, Guermazi A.

Osteoarthritis Cartilage. 2015 Jan;23 Suppl 1:S59-68. doi: 10.1016/j.joca.2014.09.018.

15.

Imaging atlas for eligibility and on-study safety of potential hip adverse events in anti-NGF studies (Part 2).

Roemer FW, Hayes CW, Miller CG, Hoover K, Guermazi A.

Osteoarthritis Cartilage. 2015 Jan;23 Suppl 1:S43-58. doi: 10.1016/j.joca.2014.09.014.

16.

The current status of imaging in anti-NGF clinical trials.

Miller CG, Guermazi A, Roemer F.

Osteoarthritis Cartilage. 2015 Jan;23 Suppl 1:S3-7. doi: 10.1016/j.joca.2014.09.002. Review. No abstract available.

17.

Imaging atlas for eligibility and on-study safety of potential knee adverse events in anti-NGF studies (Part 1).

Roemer FW, Hayes CW, Miller CG, Hoover K, Guermazi A.

Osteoarthritis Cartilage. 2015 Jan;23 Suppl 1:S22-42. doi: 10.1016/j.joca.2014.09.015.

18.

Imaging of cartilage and bone: promises and pitfalls in clinical trials of osteoarthritis.

Eckstein F, Guermazi A, Gold G, Duryea J, Hellio Le Graverand MP, Wirth W, Miller CG.

Osteoarthritis Cartilage. 2014 Oct;22(10):1516-32. doi: 10.1016/j.joca.2014.06.023. Review.

19.

Conversion of S-phenylsulfonylcysteine residues to mixed disulfides at pH 4.0: utility in protein thiol blocking and in protein-S-nitrosothiol detection.

Reeves BD, Joshi N, Campanello GC, Hilmer JK, Chetia L, Vance JA, Reinschmidt JN, Miller CG, Giedroc DP, Dratz EA, Singel DJ, Grieco PA.

Org Biomol Chem. 2014 Oct 28;12(40):7942-56. doi: 10.1039/c4ob00995a. Epub 2014 Jul 2.

20.

Effects of high glucose on integrin activity and fibronectin matrix assembly by mesangial cells.

Miller CG, Pozzi A, Zent R, Schwarzbauer JE.

Mol Biol Cell. 2014 Aug 15;25(16):2342-50. doi: 10.1091/mbc.E14-03-0800. Epub 2014 Jun 18.

21.

Measurement error in the assessment of radiographic progression in rheumatoid arthritis (RA) clinical trials: the smallest detectable change (SDC) revisited.

Navarro-Compán V, van der Heijde D, Ahmad HA, Miller CG, Wolterbeek R, Landewé R.

Ann Rheum Dis. 2014 Jun;73(6):1067-70. doi: 10.1136/annrheumdis-2012-202939. Epub 2013 Apr 20.

PMID:
23606704
22.

Rosiglitazone decreases bone mineral density and increases bone turnover in postmenopausal women with type 2 diabetes mellitus.

Bilezikian JP, Josse RG, Eastell R, Lewiecki EM, Miller CG, Wooddell M, Northcutt AR, Kravitz BG, Paul G, Cobitz AR, Nino AJ, Fitzpatrick LA.

J Clin Endocrinol Metab. 2013 Apr;98(4):1519-28. doi: 10.1210/jc.2012-4018. Epub 2013 Feb 28.

PMID:
23450056
23.

Rate of adjudication of radiological progression in rheumatoid arthritis randomized controlled trials depending on preset limits of agreement: a pooled analysis from 15 randomized trials.

Navarro-Compán V, Landewé R, Ahmad HA, Miller CG, Xu D, Wolterbeek R, van der Heijde D.

Rheumatology (Oxford). 2013 Aug;52(8):1404-7. doi: 10.1093/rheumatology/kes398. Epub 2013 Jan 16.

PMID:
23329683
24.

Considerations when designing a disease-modifying osteoarthritis drug (DMOAD) trial using radiography.

Hellio Le Graverand MP, Clemmer RS, Brunell RM, Hayes CW, Miller CG, Vignon E.

Semin Arthritis Rheum. 2013 Aug;43(1):1-8. doi: 10.1016/j.semarthrit.2012.11.006. Epub 2013 Jan 2.

PMID:
23290692
25.

A 2-year randomised, double-blind, placebo-controlled, multicentre study of oral selective iNOS inhibitor, cindunistat (SD-6010), in patients with symptomatic osteoarthritis of the knee.

Hellio le Graverand MP, Clemmer RS, Redifer P, Brunell RM, Hayes CW, Brandt KD, Abramson SB, Manning PT, Miller CG, Vignon E.

Ann Rheum Dis. 2013 Feb;72(2):187-95. doi: 10.1136/annrheumdis-2012-202239. Epub 2012 Nov 10.

PMID:
23144445
26.

Mechanism of action study to evaluate the effect of rosiglitazone on bone in postmenopausal women with type 2 diabetes mellitus: rationale, study design and baseline characteristics.

Fitzpatrick LA, Bilezikian JP, Wooddell M, Paul G, Kolatkar NS, Nino AJ, Miller CG, Bogado CE, Arnaud CD, Cobitz AR.

J Drug Assess. 2011 Dec 16;1(1):11-9. doi: 10.3109/21556660.2011.641703. eCollection 2012.

27.

The antibiotic dehydrophos is converted to a toxic pyruvate analog by peptide bond cleavage in Salmonella enterica.

Circello BT, Miller CG, Lee JH, van der Donk WA, Metcalf WW.

Antimicrob Agents Chemother. 2011 Jul;55(7):3357-62. doi: 10.1128/AAC.01483-10. Epub 2011 May 2.

28.

Quantitative imaging test approval and biomarker qualification: interrelated but distinct activities.

Buckler AJ, Bresolin L, Dunnick NR, Sullivan DC, Aerts HJ, Bendriem B, Bendtsen C, Boellaard R, Boone JM, Cole PE, Conklin JJ, Dorfman GS, Douglas PS, Eidsaunet W, Elsinger C, Frank RA, Gatsonis C, Giger ML, Gupta SN, Gustafson D, Hoekstra OS, Jackson EF, Karam L, Kelloff GJ, Kinahan PE, McLennan G, Miller CG, Mozley PD, Muller KE, Patt R, Raunig D, Rosen M, Rupani H, Schwartz LH, Siegel BA, Sorensen AG, Wahl RL, Waterton JC, Wolf W, Zahlmann G, Zimmerman B.

Radiology. 2011 Jun;259(3):875-84. doi: 10.1148/radiol.10100800. Epub 2011 Feb 15.

29.

Time trends in autism.

Miller CG.

Isr Med Assoc J. 2010 Nov;12(11):711-2. No abstract available.

30.

Fibroblast-secreted hepatocyte growth factor plays a functional role in esophageal squamous cell carcinoma invasion.

Grugan KD, Miller CG, Yao Y, Michaylira CZ, Ohashi S, Klein-Szanto AJ, Diehl JA, Herlyn M, Han M, Nakagawa H, Rustgi AK.

Proc Natl Acad Sci U S A. 2010 Jun 15;107(24):11026-31. doi: 10.1073/pnas.0914295107. Epub 2010 Jun 1.

31.

Periostin, a cell adhesion molecule, facilitates invasion in the tumor microenvironment and annotates a novel tumor-invasive signature in esophageal cancer.

Michaylira CZ, Wong GS, Miller CG, Gutierrez CM, Nakagawa H, Hammond R, Klein-Szanto AJ, Lee JS, Kim SB, Herlyn M, Diehl JA, Gimotty P, Rustgi AK.

Cancer Res. 2010 Jul 1;70(13):5281-92. doi: 10.1158/0008-5472.CAN-10-0704. Epub 2010 Jun 1. Erratum in: Cancer Res. 2010 Aug 1;70(15):6398.

32.

Development of a clinical workflow tool to enhance the detection of vertebral fractures: accuracy and precision evaluation.

Brett A, Miller CG, Hayes CW, Krasnow J, Ozanian T, Abrams K, Block JE, van Kuijk C.

Spine (Phila Pa 1976). 2009 Oct 15;34(22):2437-43. doi: 10.1097/BRS.0b013e3181b2eb69.

PMID:
19829258
33.

Sexual intercourse involving giant sperm in Cretaceous ostracode.

Matzke-Karasz R, Smith RJ, Symonova R, Miller CG, Tafforeau P.

Science. 2009 Jun 19;324(5934):1535. doi: 10.1126/science.1173898.

34.

Tobacco smoke induces urokinase-type plasminogen activator and cell invasiveness: evidence for an epidermal growth factor receptor dependent mechanism.

Du B, Leung H, Khan KM, Miller CG, Subbaramaiah K, Falcone DJ, Dannenberg AJ.

Cancer Res. 2007 Sep 15;67(18):8966-72.

35.

Pharmacokinetic-pharmacodynamic correlation from mouse to human with pazopanib, a multikinase angiogenesis inhibitor with potent antitumor and antiangiogenic activity.

Kumar R, Knick VB, Rudolph SK, Johnson JH, Crosby RM, Crouthamel MC, Hopper TM, Miller CG, Harrington LE, Onori JA, Mullin RJ, Gilmer TM, Truesdale AT, Epperly AH, Boloor A, Stafford JA, Luttrell DK, Cheung M.

Mol Cancer Ther. 2007 Jul;6(7):2012-21.

36.

Visceral and subcutaneous adiposity measurements in adults: influence of measurement site.

Ellis KJ, Grund B, Visnegarwala F, Thackeray L, Miller CG, Chesson CE, El-Sadr W, Carr A; Strategies for Management of Anti-Retroviral Therapy (SMART) Study Group.

Obesity (Silver Spring). 2007 Jun;15(6):1441-7.

37.

Searchable high-resolution 2D gel proteome of the human colon crypt.

Patel BB, Li XM, Dixon MP, Blagoi EL, Seeholzer SH, Chen Y, Miller CG, He YA, Tetruashvily M, Chaudhry AH, Ke E, Xie J, Cooper H, Bellacosa A, Clapper ML, Boman BM, Zhang T, Litwin S, Ross EA, Conrad P, Crowell JA, Kopelovich L, Knudson A, Yeung AT.

J Proteome Res. 2007 Jun;6(6):2232-8. Epub 2007 Apr 20.

PMID:
17444668
38.

Splenic and immune alterations of the Sparc-null mouse accompany a lack of immune response.

Rempel SA, Hawley RC, Gutiérrez JA, Mouzon E, Bobbitt KR, Lemke N, Schultz CR, Schultz LR, Golembieski W, Koblinski J, VanOsdol S, Miller CG.

Genes Immun. 2007 Apr;8(3):262-74. Epub 2007 Mar 8.

PMID:
17344888
39.

Related to testes-specific, vespid, and pathogenesis protein-1 (RTVP-1) is overexpressed in gliomas and regulates the growth, survival, and invasion of glioma cells.

Rosenzweig T, Ziv-Av A, Xiang C, Lu W, Cazacu S, Taler D, Miller CG, Reich R, Shoshan Y, Anikster Y, Kazimirsky G, Sarid R, Brodie C.

Cancer Res. 2006 Apr 15;66(8):4139-48.

40.

Characterization of a periplasmic S1-like nuclease coded by the Mesorhizobium loti symbiosis island.

Pimkin M, Miller CG, Blakesley L, Oleykowski CA, Kodali NS, Yeung AT.

Biochem Biophys Res Commun. 2006 Apr 28;343(1):77-84. Epub 2006 Feb 28.

PMID:
16529713
41.

Antitumour efficacy of VEGFR2 tyrosine kinase inhibitor correlates with expression of VEGF and its receptor VEGFR2 in tumour models.

Dev IK, Dornsife RE, Hopper TM, Onori JA, Miller CG, Harrington LE, Dold KM, Mullin RJ, Johnson JH, Crosby RM, Truesdale AT, Epperly AH, Hinkle KW, Cheung M, Stafford JA, Luttrell DK, Kumar R.

Br J Cancer. 2004 Oct 4;91(7):1391-8.

42.
43.

DapE can function as an aspartyl peptidase in the presence of Mn2+.

Broder DH, Miller CG.

J Bacteriol. 2003 Aug;185(16):4748-54.

45.

Herpes simplex virus latency-associated transcript gene function.

Kent JR, Kang W, Miller CG, Fraser NW.

J Neurovirol. 2003 Jun;9(3):285-90. Review.

PMID:
12775412
46.

Failed anterior cervical foraminotomy.

Hacker RJ, Miller CG.

J Neurosurg. 2003 Mar;98(2 Suppl):126-30.

PMID:
12650395
47.

Structure of peptidase T from Salmonella typhimurium.

Håkansson K, Miller CG.

Eur J Biochem. 2002 Jan;269(2):443-50.

49.

Low dose intrathecal ropivacaine with or without sufentanil provides effective analgesia and does not impair motor strength during labour: a pilot study.

Soni AK, Miller CG, Pratt SD, Hess PE, Oriol NE, Sarna MC.

Can J Anaesth. 2001 Jul-Aug;48(7):677-80.

PMID:
11495875
50.

Predictors of breakthrough pain during labor epidural analgesia.

Hess PE, Pratt SD, Lucas TP, Miller CG, Corbett T, Oriol N, Sarna MC.

Anesth Analg. 2001 Aug;93(2):414-8, 4th contents page.

PMID:
11473872

Supplemental Content

Loading ...
Support Center